Dermapharm Holding SE operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dermapharm Holding SE with three other
companies in this sector in GERMANY :
sales of 446.44 million Euro [US$527.70 million]
of which 76%
was EVT Execute),
Eckert & Ziegler Strahlen- und Medizinte
(178.49 million Euro [US$210.98 million]
of which 59%
was Isotope Products), and
(419.10 million Euro [US$495.39 million]
of which 89%
Dermapharm Holding SE reported sales of 700.88 million Euro (US$828.46 million)
December of 2019.
increase of 22.4%
versus 2018, when the company's sales were 572.42 million Euro.
This was the fourth straight year of sales growth at Dermapharm Holding SE.
Sales of Pharmaceuticals and Other Products saw an increase
15.1% in 2019, from
334.66 million Euro to 385.15 million Euro.